So many questions, so little time

Journal of Infectious Diseases

Volumn 207, Issue 2, 2013, Pages 208-210

  Donis, Ruben O ^a   Cox, Nancy J ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

BANGLADESH; BIRD DISEASE; CHINA; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE CONTROL; DISEASE SEVERITY; ENDEMIC DISEASE; GENE EXPRESSION; INDONESIA; INFECTION CONTROL; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MICROARRAY ANALYSIS; NETHERLANDS; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED STATES; VIET NAM; VIRUS DETECTION; WORLD HEALTH ORGANIZATION;

EID: 84871751603     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis529     Document Type: Note

References (24)

1. Claas EC, Osterhaus AD, van Beek R, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998; 351:472-7.
2. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998; 279:393-6.
3. FAO-DAH. H5N1 HPAI Global Overview. January-March 2012 http://www.fao.org/docrep/015/an388e/an388e.pdf. Accessed July 24 2012.
4. WHO-CSR. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. (6 July), 2012. Available at: http://www.who.int/ influenza/human-animal-interface/EN-GIP-20120706CumulativeNumberH5N 1 c ases. pdf. Access July 23 2012.
5. Herfst S, Schrauwen EJ, Linster M, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012; 336:1534-41.
6. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 2012; 486:420-8.
7. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 2012; 336:1541-7.
8. FAO-DAH. Stamping out H5N1 avian influenza could take decades, 2011. http://www.fao.org/news/story/en/item/66118/icode/. Accessed July 23 2012.
9. Osterholm MT, Kelley NS. Mammalian-transmissible H5N1 influenza: facts and perspective. MBio 2012; 3:e00045.
10. Wang TT, Parides MK, Palese P. Seroevi-dence for H5N1 influenza infections in humans: meta-analysis. Science 2012; 335:1463.
11. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-7.
12. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004; 363:617-9.
13. Cheung CY, Poon LL, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002; 360:1831-7.
14. Jagger BW, Wise HM, Kash JC, et al. An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response. Science 2012; 337: 199-204.
15. Sakabe S, Iwatsuki-Horimoto K, Takano R, et al. Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses. J Gen Virol 2011; 92:1428-34.
16. Spesock A, Malur M, Hossain MJ, et al. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J Virol 2011; 85:7048-58.
17. Belser JA, Wadford DA, Pappas C, et al. PathogenesisofpandemicinfluenzaA(H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J Virol 2010;84: 4194-203.
18. Wolff T, Ludwig S. Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J Interferon Cytokine Res 2009; 29:549-57.
19. Fernandez-Sesma A, Marukian S, Ebersole BJ, et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 2006; 80:6295-304.
20. Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006; 443:578-81.
21. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA 2009; 106:3455-60.
22. Billharz R, Zeng H, Proll SC, et al. The NS1 protein of the 1918 pandemic influenza virus blocks host interferon and lipid metabolism pathways. J Virol 2009; 83:10557-70.
23. Jackson D, Hossain MJ, Hickman D, Perez DRLamb RA. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci USA 2008; 105:4381-6.
24. Office of Biotechnology Activities N.I.H. United States Government Policy for Oversight of Life Sciences Dual Use Research of Concern, 2012. Available at: http://oba.od. nih.gov/oba/biosecurity/pdf/united-states-government-policy- for-oversight-of-durc-final-version-032812.pdf. Accessed July 22 2012.